Government of Bolivia Report issue

Government Phase 3 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00290420
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Ministerio de Salud de Bolivia, Programa Nacional de Leishmaniasis | Ministry of Health, Bolivia

Active Ingredients

Drugs in Phase 4 Trials (1)

chloroquine (1 trial)

Drugs in Phase 3 Trials (2)

miltefosine (impavido) (1 trial)

paromomycin (humatin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leishmaniasis (Phase 3)

Leishmaniasis, Cutaneous (Phase 3)

Malaria (Phase 4)

Malaria, Vivax (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3